ChengDa Pharmaceuticals Co., Ltd. (SHE:301201)
China
· Delayed Price · Currency is CNY 41.23
+0.87 (2.16%)
Apr 29, 2026, 4:00 PM EDT
ChengDa Pharmaceuticals Revenue
ChengDa Pharmaceuticals had revenue of 128.24M CNY in the quarter ending March 31, 2026, with 68.06% growth. This brings the company's revenue in the last twelve months to 458.30M, up 48.54% year-over-year. In the year 2025, ChengDa Pharmaceuticals had annual revenue of 406.37M with 21.99% growth.
Revenue (ttm)
458.30M
Revenue Growth
+48.54%
P/S Ratio
13.63
Revenue / Employee
755.03K
Employees
656
Market Cap
6.25B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jinghua Pharmaceutical Group | 1.46B |
| Guizhou Xinbang Pharmaceutical | 5.62B |
| Shanghai Kaibao Pharmaceutical CO.,Ltd | 1.15B |
| Luoxin Pharmaceuticals Group Stock | 2.37B |
| Heilongjiang ZBD Pharmaceutical | 1.59B |
| Hunan Jiudian Pharmaceutical | 3.01B |
| Jiangsu Lianhuan Pharmaceutical | 2.71B |
| Tibet Duo Rui Pharmaceutical | 177.11M |